Published in J Bone Miner Res on August 01, 1989
Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest (1994) 2.33
Leptin and the sympathetic connection of fat to bone. Osteoporos Int (2007) 1.61
Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health (1993) 1.30
Estrogen status and heredity are major determinants of premenopausal bone mass. J Clin Invest (1992) 1.08
Bone mineral density reference norms for Hong Kong Chinese. Osteoporos Int (2005) 1.00
The effect of breast-feeding duration on bone mineral density in postmenopausal Turkish women: a population-based study. Arch Med Sci (2011) 0.97
Chromosomal regions 22q13 and 3p25 may harbor quantitative trait loci influencing both age at menarche and bone mineral density. Hum Genet (2008) 0.91
A systematic review of interventions by healthcare professionals on community-dwelling postmenopausal women with osteoporosis. Osteoporos Int (2010) 0.86
Lumbar spine peak bone mass and bone turnover in men and women: a longitudinal study. Osteoporos Int (2008) 0.85
Velocities of bone mineral accrual in black and white American children. J Bone Miner Res (2010) 0.84
Cross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthma. Thorax (1997) 0.84
Pubertal timing and body mass index gain from birth to maturity in relation with femoral neck BMD and distal tibia microstructure in healthy female subjects. Osteoporos Int (2011) 0.81
Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group. Osteoporos Int (1997) 0.81
The influence of age at menarche on cross-sectional geometry of bone in young adulthood. Bone (2012) 0.80
Racial difference in the correlates of bone mineral content/density and age at peak among reproductive-aged women. Osteoporos Int (2009) 0.78
Higher prevalence of osteoporosis among female Holocaust survivors. Osteoporos Int (2007) 0.78
Influence of body parameters on female peak bone mass and bone loss. Osteoporos Int (1993) 0.78
Understanding osteoporosis. West J Med (1991) 0.76
Premenopausal Osteoporosis. Endocrinol Metab Clin North Am (2016) 0.75
Bone mass and lifestyle related factors: a comparative study between Japanese and Inner Mongolian young premenopausal women. Osteoporos Int (2004) 0.75
Ulnar nerve dislocation and snapping triceps syndrome: diagnosis with dynamic sonography--report of three cases. Radiology (2001) 3.03
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med (2000) 2.80
Eating disorders. N Engl J Med (1999) 2.77
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab (2010) 2.33
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 2.30
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J (1980) 2.29
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int (2003) 2.13
Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab (1994) 2.09
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Osteoporosis in women with anorexia nervosa. N Engl J Med (1984) 1.99
Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab (2001) 1.95
The clinical course of osteoporosis in anorexia nervosa. A longitudinal study of cortical bone mass. JAMA (1991) 1.93
Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr (2001) 1.91
Three-compartment wrist arthrography: use of a low-iodine-concentration contrast agent to decrease study time. Radiology (1989) 1.91
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.91
The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab (1999) 1.89
A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab (1996) 1.85
Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med (2000) 1.74
The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience (2010) 1.69
Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.68
US of soft-tissue foreign bodies and associated complications with surgical correlation. Radiographics (2001) 1.66
The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab (1995) 1.64
Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab (1989) 1.61
Osteopenia in men with a history of delayed puberty. N Engl J Med (1992) 1.59
Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab (1998) 1.57
Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab (1996) 1.54
Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res (1986) 1.54
Decreased bone density in hyperprolactinemic women. N Engl J Med (1980) 1.53
Indications for radiography in patients with acute ankle injuries: role of the physical examination. AJR Am J Roentgenol (1991) 1.52
Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord (2000) 1.49
Nephrogenous cyclic adenosine monophosphate as a parathyroid function test. J Clin Invest (1977) 1.47
Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology (1989) 1.46
An illustrated tutorial of musculoskeletal sonography: part I, introduction and general principles. AJR Am J Roentgenol (2000) 1.44
Stimulation by artificial lighting of calcium absorption in elderly human subjects. Nature (1971) 1.38
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med (1994) 1.36
Easily missed injuries around the knee. Radiographics (1994) 1.35
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med (1987) 1.34
Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med (1996) 1.34
Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab (1992) 1.34
Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med (1986) 1.34
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med (2000) 1.33
Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med (1981) 1.33
Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab (2004) 1.31
Sonography and radiography of soft-tissue foreign bodies. AJR Am J Roentgenol (2001) 1.31
Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab (1999) 1.31
Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. JAMA (1998) 1.30
Hyperparathyroidism during pregnancy. Am J Surg (1976) 1.29
Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2006) 1.27
Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest (1990) 1.27
Sonography of diabetic muscle infarction with MR imaging, CT, and pathologic correlation. AJR Am J Roentgenol (2000) 1.26
A consensus on the diagnosis and treatment of acromegaly complications. Pituitary (2013) 1.26
Effects of fasting and glucose infusion on basal and overnight leptin concentrations in normal-weight women. Am J Clin Nutr (1997) 1.26
Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab (1996) 1.26
Evaluation of bone mineral density using three-dimensional solid state phosphorus-31 NMR projection imaging. Calcif Tissue Int (1998) 1.25
Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med (1987) 1.23
Inflammatory cardiovascular risk markers in women with hypopituitarism. J Clin Endocrinol Metab (2001) 1.20
Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporos Int (2003) 1.19
Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (1989) 1.18
Primary medical therapy of micro- and macroprolactinomas in men. J Clin Endocrinol Metab (2000) 1.17
Sonographic detection of Baker's cysts: comparison with MR imaging. AJR Am J Roentgenol (2001) 1.17
An evaluation of antibodies and clinical resistance to salmon calcitonin. J Clin Invest (1972) 1.16
Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis (2000) 1.16
A comparison of lateral versus anterior-posterior spine dual energy x-ray absorptiometry for the diagnosis of osteopenia. J Clin Endocrinol Metab (1994) 1.15
Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab (1996) 1.15
Gastric volvulus. An unusual complication after pneumonectomy. Am J Surg (1967) 1.14
Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome. J Clin Endocrinol Metab (1999) 1.14
Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma. N Engl J Med (1970) 1.13
Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment. Gastroenterology (1982) 1.11
Intraarticular osteoid osteoma: sonographic findings in three patients with radiographic, CT, and MR imaging correlation. AJR Am J Roentgenol (2001) 1.10
Current management practices for acromegaly: an international survey. Pituitary (2011) 1.10
Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab (1996) 1.09
Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab (2004) 1.09
Clinical review 45: Clinically nonfunctioning pituitary adenomas. J Clin Endocrinol Metab (1993) 1.09
Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab (1981) 1.08
Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab (1990) 1.07
Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med (1992) 1.07
Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med (1999) 1.06
Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med (1986) 1.05
Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism. Metabolism (1975) 1.04